Canbiola Appoints Additional Members to its Corporate Advisory Board

Adds Medical and Healthcare Expertise

Hicksville, NY - (NewMediaWire) - March 25, 2019 - Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today the appointments of Mr. Jason Winn and Dr. Mehran Peter Ghazvini to its Corporate Advisory Board. Both have been active proponents for chronic pain management and tissue healing solutions.

Canbiola Chief Executive Officer, Marco Alfonsi, commented, “We are pleased to have both Mr. Winn and Dr. Ghazvini join our Corporate Advisory Board. We look forward to their knowledge, advice and relationships in the medical field as we increase the awareness and distribution of our CBD products.”

Mr. Jason Winn stated, “I am excited to be part of the Canbiola team and provide my insights on the legal side of health care. My current legal work includes areas affecting health care practitioners and dealings with licensed health care providers. The recent passage of the U.S. Farm Act opens the door for companies such as Canbiola to address a need with CBD products.”

Dr. Mehran Peter Ghazvini stated, “I am thrilled to join the Canbiola team and lend my many years of medical expertise. As a rehabilitation chiropractor, I am always seeking the latest and greatest methods and medicines to improve patient outcomes and achieve success in restoring a patient’s functional abilities. I believe Canbiola’s products, incorporating CBD, enable patient success in chronic pain treatment and rehabilitation.”

Jason D. Winn, Esquire, is a 1996 graduate of the University of Maryland and received his Juris Doctorate from Nova Southeastern University - Shepard Broad Law in Ft. Lauderdale, Florida in 2000. Mr. Winn was admitted to the Florida Bar in 2001. From 2001 until 2004, Mr. Winn worked for the Assistant Public Defender in the Fifth Judicial Circuit where he conducted over 15 jury trials, numerous non-jury trials, and many hearings including, violations of probation, restitution, and early termination motions for defendants in Juvenile, Misdemeanor and Felony Court. Mr. Winn was also an adjunct professor at Lake Sumter Community College teaching Business Law during this time.  In 2003, Mr. Winn was appointed by Governor Bush to serve a one-year term on the Judicial Nominating Commission for Judicial Compensation Judges. From 2004-2006 Mr. Winn worked for the law office of Clyde M. Taylor, Jr. focusing on both state and federal criminal defense and parole violation hearings. Beginning in 2005, he opened his own practice, Winn Law, where he is managing partner and continues to focus on criminal, administrative, governmental, civil, and wills.  Mr. Winn currently serves as general counsel for the Florida Osteopathic Medical Association (FOMA), the Florida Podiatric Medical Association (FPMA) and the Florida Society of Hearing Healthcare Professionals (FSHHP). Mr. Winn lectures throughout Florida on the Laws and Rules that affect health care practitioners, including Osteopathic, Allopathic, Podiatric, and various other licensed health care providers.  He is a member of the Florida Bar, Tallahassee Bar, Legal Services of North Florida, a lifetime member of the state Florida Association of Criminal Defense Lawyers (FACDL), and the local FACDL chapter. As a member of the Tallahassee Bar, Mr. Winn volunteers his legal services to the Wakulla County Senior Citizens Center, and Legal Services of North Florida.

Dr. Mehran Peter Ghazvini is a Tallahassee, Florida based male chiropractor who is specialized as a Rehabilitation Chiropractor. Dr. Ghazvini is focused on restoring a patient's functional abilities to pre-injury or pre-disease status. Functional abilities are defined as those activities in one's daily life, work, or sports and recreational activities that an individual participates in. Relevant impairments (e.g. strength, endurance, flexibility, motor control, etc.) are often intermediate goals of rehabilitation, but the final goal of successful care is return to participation in activities in which the patient was successful before the onset of the injury or disease. Essential to a rehabilitation approach is a focus on patient-centered outcomes such as independence and self-management or self-care skills.

About Canbiola, Inc.

Canbiola, Inc. (OTCQB: CANB) is a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews,, isolate, gel caps, and concentrates. Canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure CBD products are legal in all 50 states. Hemp CBD is the non-psychoactive component (No THC) used for treatment of pain, inflammation, and wellness programs. For more information about Canbiola, Inc., please visit:

Additionally, Canbiola’s wholly owned subsidiary, Pure Health Products, based in Lacey, WA, is its prime development laboratory and production facility. Canbiola’s Duramed division has recently rolled out a durable medical device via its Doctor network to treat patients with injuries via application of an in-home ultrasound sustained acoustic device (SAM) for pain and inflammation reduction.

Forward-Looking Statements

Forward-looking statements and risks and uncertainties discussed in this letter contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price.

Follow Canbiola on: 

Twitter @CanbiolaHealth

Instagram or @canbiola_cbd or @canbiola_medical_cbd

Follow us on Twitter and Facebook

Investors and Media:
(516) 595-9544
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.